novoGI
7
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
14%
1 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
COMPRES - COMpression Anastomosis Ring (CAR™ 27/ColonRing™) Post maRketing Evaluation Study
Role: lead
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Role: lead
A Post Marketing Study of Angel of Water™ for Colon Cleansing as Preparation for Colonoscopy
Role: lead
Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis
Role: lead
Compression Anastomosis Using the CAR™ 27
Role: collaborator
Compression Anastomosis Using the CAR™ 27
Role: collaborator
Compression Anastomosis Using the Compression Anastomosis Ring (CAR™ 27)
Role: collaborator
All 7 trials loaded